^
Phase 1
IDRx, Inc.
Recruiting
Last update posted :
01/17/2025
Initiation :
08/01/2022
Primary completion :
04/24/2026
Completion :
09/13/2026
PDGFRA
|
KIT mutation • PDGFRA mutation • PDGFRA exon 18 mutation
|
sunitinib • velzatinib (GSK6042981)